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Introduction
Uncontrolled hyperglycemia and iatrogenic hypoglycemia represent common inpatient quality and safety issues associated with a broad range of adverse outcomes [1] [2] [3] [4] , and insulin is one of the most common sources of inpatient adverse drug events [2, 5, 6] . Professional societies, standards organizations and "Partnerships for Patients" efforts have highlighted the importance of optimizing inpatient glycemic control and reducing hypoglycemia. [2] [3] [4] [7] [8] [9] [10] [11] Despite significant gains in inpatient glycemic control and dissemination of our glycemic management strategies in past years at our institution [8, 9, [12] [13] [14] [15] , we noted multiple continuing opportunities for improvement. These included knowledge deficits in our providers, improper insulin prescribing practices, and lapses in coordination of care. We were particularly motivated to address hypoglycemia after we examined the quality of hypoglycemia management and the most common inciting factors for iatrogenic hypoglycemia in our medical center in 2008, [16] and again in 2011. Our studies found that over half of hypoglycemia cases were potentially preventable. The most common remedial causes of iatrogenic hypoglycemia were:
1. Prescribing insulin regimens that do not conform to best-practice standards.
2. Failure to appropriately identify and mitigate the source of an initial hypoglycemic event, leading to recurrent hypoglycemic events.
3. Failure to anticipate and appropriately respond to unexpected interruptions of nutrition in a patient receiving nutritional insulin, leading to nutrition / insulin mismatch.
We found that nursing staff did not follow the hypoglycemia management protocol reliably. We observed long glucose re-testing delays after hypoglycemic events, poor documentation, and long intervals until hypoglycemia resolution. Others have reported similar findings. [17] [18] [19] DOI:10.4158/EP14367.OR © 2014 AACE.
We hypothesized that we could significantly reduce iatrogenic hypoglycemia in our non-ICU population by introducing a hypoglycemia reduction bundle addressing these causes, while simultaneously continuing to reduce uncontrolled hyperglycemia. We further hypothesized that identifying and addressing quality outliers in real time (as opposed to relying solely on month-to-month glucometrics) would further reduce undesirable glycemic excursions. We have termed this form of active surveillance measure-vention, coupling real-time measurement and identification of uncontrolled patients to spur concurrent interventions. The measure-vention technique was first demonstrated to be successful in optimizing thromboprophylaxis, and has since been utilized for a number of improvement efforts in our institution and others. [20] [21] [22] We report the impact of our improvement methods and implementation of a hypoglycemia reduction bundle on inpatient hypoglycemia, hyperglycemia, hypoglycemia management below, in an effort to describe and disseminate successful strategies for improvement to inpatient glycemic control teams.
Methods

Study design, population, and data sources
We used a proven performance improvement framework [8, 9] and conducted institutional review board (IRB) approved prospective observational research in parallel with performance improvement efforts, with a waiver of individual informed consent.
The population of interest was defined as hospitalized adult non-critical care (non-ICU) patients with hyperglycemia and / or a diagnosis of Diabetes (ICD-9 codes 250.xx), admitted to our 550 bed academic Patients without a Diabetes diagnosis who did not meet criteria for hyperglycemia were excluded from the analysis. Obstetrics wards / pregnant patients, and pediatric age groups under the age of sixteen were also excluded. Glucometrics (described below) were reported to the improvement team and other groups on a regular basis throughout the intervention period. 
Interventions and Improvement Techniques
Subcutaneous insulin order sets, protocols, and an insulin management algorithm
Extensive clinical decision support (CDS) to guide appropriate subcutaneous insulin ordering and glycemic monitoring was integrated into our electronic health record (EHR) order sets. The CDS offered guidance on dosing, and matched pre-formatted insulin regimens with a variety of nutritional intake patterns (Figure 1) , allowing incorporation of standardized administration instructions, indications, and holding parameters to help improve reliable and appropriate insulin administration. Insulin could now only easily be ordered via the order set. While our electronic health record makes it feasible to order insulin by alternative methods, it is inconvenient, essentially establishing a forcing function to increase exposure to the embedded protocol-driven CDS. A glucose management page displayed several variables that impact glycemic control together in an organized manner (Figure 2) , enabling providers to quickly assess the patient's glycemic trend and contributing factors. Glycemic outlier reports capturing all patients in the hospital with a BG <80mg/dL or >180mg/dL during the preceding three days were integrated into our EHR, allowing the inpatient diabetes team to perform active surveillance for potential lapses in care. The roster of glycemic outliers linked to the graphic glucose management page served as the basis for our measure-vention process. The diabetes team was empowered by select services (Transplant services, Cardiology) to initiate pre-authorized consultation for inpatients with triggers such as poor glycemic control or new insulin initiations, and in some cases, write orders to expedite care or avoid transcription errors in more complicated circumstances. For all other services without these agreements, the inpatient diabetes team contacted the primary team to offer advice or consultation, and the primary team executed all orders.
Hypoglycemia reduction bundle
We implemented a bundle of interventions to address the top causes of remediable iatrogenic hypoglycemia from our previous studies. Table 1 summarizes the Hypoglycemia Reduction Bundle strategies. To improve prescribing practices, we implemented pre-formatted insulin regimens in our updated insulin order sets in the early transition period (TP2) as described above. These order sets were designed to guide providers in ordering insulin in a safe, standardized manner, while retaining ease of use and flexibility. CDS was added to encourage more liberal glycemic targets and lower insulin dosing for patients with hypoglycemia risk factors, comfort care situations, and the like.
During the revision of the hypoglycemia management protocol in early TP2, we included a step highlighting the assessment of the initial hypoglycemia episode in order to determine the cause and appropriate steps to prevent further episodes. Education on this step and how to assess the cause of initial hypoglycemia was rolled out through our DIG group, discussed at monthly nursing unit meetings, and reinforced by the measure-vention process. Timely management of hypoglycemia and standardized documentation were also emphasized in educational efforts and audited with feedback to nursing staff.
In TP2 the "Nutrition on Hold Unexpectedly" algorithm ( Figure 3 ) was introduced to address nutritional insulin mismatch, the most prominent source of iatrogenic hypoglycemia in our institution. Common scenarios included sudden interruption of enteral tube feeds or TPN, unscheduled NPO status, and nausea or poor appetite in patients on full doses of nutritional insulin. Complimenting this protocol, comments allowing nurses to hold the nutritional insulin dose until after the meal in the setting of nausea or poor appetite, and guidance to adjust the dose of nutritional insulin based on the percent of tray consumed were added to nutritional insulin orders and the medication administration record.
"Give within 15 minutes of meal: may give just after meal if patient nauseated or has poor appetite. If lispro insulin is deferred until after the meal, administer as follows: give 0 units if patient ate less than
50% of meal, give half of the scheduled dose if patient ate 50% of meal, and give the full dose if patient ate more than 50% of meal. Do NOT administer nutritional lispro insulin if nutrition is interrupted."
This guidance provided nurses with the flexibility to match the dose of nutritional insulin to the amount of food consumed and reduced calls to the ordering providers.
Coordination of tray delivery, testing, and insulin administration
Problems with the coordination of tray delivery, BG testing, and insulin administration were problematic in our medical center even though we don't have "room service" delivery of meals. An internal study on tray timing and content demonstrated variability of tray arrival, and carbohydrate portions that were often oversized and not standardized. The Nutrition Services department improved standardization of the carbohydrate content of trays, timing of tray delivery and availability of low and zero carbohydrate snacks. The kitchen staff was educated on diabetes, the impact of carbohydrate servings on blood DOI:10.4158/EP14367.OR © 2014 AACE.
glucose, and the rationale for inpatient glycemic control. A schedule was made with a 15 minute window for meal cart delivery, and phone calls were initiated to each unit to announce imminent arrival or delay of the meal carts. Nursing staff and assistants were trained to treat nutrition delivery, BG testing, and insulin administration as a unified process, and audit and feedback were used to reinforce this.
Education and competency training -physicians, nurses, patients
Ordering providers were the target audience for a computerized learning module entitled "Inpatient Diabetes Management for Physicians/Providers" which focused on ten main concepts of inpatient glycemic control in a case based, pre-test/post-test format. Education slides with voice over learning were incorporated into the pre-test component and an 80% pass rate was required to document competency and earn CME credit for the post-test component. The educational module was adopted by the Hospital Medicine division then rolled out to pharmacists, dieticians, Family Medicine faculty, and Internal Medicine residents. Noon conferences reinforcing basic concepts and appropriate order set use with a case based, interactive format were held for the same groups.
Nursing education included competency training and ongoing refreshers. Safe insulin management was incorporated into the Nursing Annual Update online module, Nursing Grand Rounds and other nursing education formats, along with short, focused education at nursing unit meetings. For example, when the topic of the month is basal insulin, 2-3 minute "pearls" on basal insulin are presented followed by a few short cases applying these pearls to routine clinical practice.
A patient education series was also created to help standardize diabetes education for patients. The education series incorporated short online education videos coupled with standardized teach back DOI:10.4158/EP14367.OR © 2014 AACE.
questions, handouts, and live demonstrations to provide patients with basic information in several learning formats while improving nursing efficiency.
Unit specific reports were created to provide regular feedback to nursing units on several core measures of inpatient glycemic control including hyperglycemia, hypoglycemia and hypoglycemia management (Figure 4) . These reports show unit-specific six month trends and a one month snap shot of how each unit compares to other similar units. The performance of all units was made transparent, engendering friendly competition.
Measures and Data Collection
Glucose meter data captured each BG value, along with a patient identifier, ward, date, and time of collection. BG values < 10 mg/dL were set to 10 mg/dL and readings > 600 mg/dL were re-set to 601 mg/dL; Glucometrics summarizing rates of hyperglycemia, hypoglycemia, recurrent hypoglycemia, and the timeliness of hypoglycemia management and resolution were devised.
Glucometrics were expressed using the patient-day for most parameters, a common practice with the advantage of providing a uniform unit of time, adjusting to some degree for repeated testing around glycemic excursions and other local variations in testing patterns. [14, 23, 24] The degree of glycemic control was summarized as a day-weighted mean for the population (i.e., the mean of all readings for one patient-day, then averaged across all patient-days in that group) , the percent of patient-days with a mean (day-weighted) ≥ 180 mg/dL, and the percent of patient-days with any BG > 299 mg/dL. In a similar fashion, hypoglycemia is summarized as the percent of patient days with at least one BG < 70, and severe hypoglycemia as the percent of patient-days with any glucose < 40 mg/dL. Selected metrics were also expressed with the patient-stay as the unit of analysis (e.g. the percent of patients with at DOI:10.4158/EP14367.OR © 2014 AACE. 
Results
During the five year observation period 22,990 non-ICU patients, representing 94,900 patient-days had a diagnosis of diabetes and / or met criteria for hyperglycemia ( Table 2) . The number of patients meeting diabetes or hyperglycemia criteria increased over the years in the study, reflecting expansion of our medical center. Average length of stay, age, gender distribution, the proportion of patients with a diagnosis of diabetes, and case mix index scores did not significantly change over the three time periods.
Another marker of severity of illness, the percent of patients with any intensive care unit exposure during their stay increased from TP1 to TP2 and TP3 (19.7% vs 27.0% in TP2 and TP3, p < 0.05, Pearson chi square). The first BG values obtained during the hospitalization were analyzed. The percent of patients with the first BG ≥ 180 mg/dL was 45% in TP1, 43.1% in TP2, and 42.4% in TP3. The percent of patients with a first BG > 299 mg/dL was 9.3%, 10.1%, and 10.1%.
Hypoglycemia Rates
Analysis by patient-stay
In TP1, 13.7% (917 of 6,681) of the patients with diabetes / hyperglycemia suffered from at least one hypoglycemic event (BG < 70 mg/dL), and 2.9% (195) of the patients suffered from at least one severe hypoglycemic event (BG < 40 mg/dL) during the course of their non-ICU stay ( Table 3 
Analysis by patient-day
The percent of patient-days with hypoglycemia fell over the study period 
Hypoglycemia Management
The mean intervals for rechecking BG after a hypoglycemic event improved from 53.0 minutes to 41.7 minutes, while the mean time interval for documented resolution of a hypoglycemic event improved from 64.1 minutes to 49.0 minutes ( Table 4 ).
The improvement in recurrent hypoglycemia rate described above is also interpreted as a marker of hypoglycemia management and secondary hypoglycemia prevention, via assessment and appropriate interventions taken for the index hypoglycemic event. 
Glycemic Control and
Discussion
Our study convincingly demonstrates that a significant reduction in inpatient hypoglycemic events is possible by interventions focused on common causes of remediable hypoglycemic events, such as inappropriate insulin prescribing, failure to address unexpected nutritional interruption, and failure to respond appropriately to the first hypoglycemic event. Importantly, these reductions in hypoglycemic events are not gained at the expense of increased hyperglycemia, as we reduced unwanted hyperglycemic excursions during the same time frame.
Strengths and Limitations
Our study has several strengths. This study is large, incorporating nearly 23,000 patients and 95,000 inpatient-days of observation over a five year time period, including all patients with inclusion criteria for hyperglycemia and / or diabetes. The observation period is long enough that observation bias is not a factor. We used high quality glucometrics largely congruent with both Society of Hospital Medicine DOI:10.4158/EP14367.OR © 2014 AACE.
(SHM) Glycemic Control Task Force recommendations [14, [23] [24] [25] and Yale Glucometrics, and examined data by both patient-stay and patient-day.
The improvements seen are fairly dramatic for an institution in absolute terms, because inpatient hyperglycemia and hypoglycemia are relatively common. For example, on an annualized basis for our 550 bed hospital, our efforts resulted in 236 fewer hypoglycemic stays and 296 fewer hypoglycemic days. Both ends of the extreme glycemic spectrum saw improvement, creating a win/win situation for glycemic control efforts. On an annualized basis, for example, 98 fewer patients suffer from severe (<40 mg/dL) hypoglycemia, while also averting 939 patient-days with severe hyperglycemia (> 299 mg/dL).
Other institutions should be able to replicate many of our interventions, including protocol driven order sets with embedded CDS, flow sheets, educational programs, and much of the hypoglycemia reduction bundle. Measure-vention techniques may be more dependent on the environment for success. Daily reports identifying outliers in glycemic control should be fairly easy to replicate, but medical centers need an effective means to further triage these patients, and intervene if a true deficit in care is present.
We successfully modeled triggered consultation in our institution, allowing for glycemic management consultations based on measure-vention, and this was very well accepted in our institution, but this acceptance could vary.
The main limitation of this study lies in the observational study design. There were multiple interventions and improvement strategies deployed in concert, and it is difficult to specify which interventions had the largest impact. Since we did not perform a randomized trial, one might reasonably question if demographic shifts or secular changes were responsible for the improvement, rather than our interventions. However, several factors make this unlikely. First, the study population is well-DOI:10.4158/EP14367.OR © 2014 AACE. defined, having diabetes or documented hyperglycemia inclusion criteria in all three time periods.
Second, the demographics and severity of illness remained constant, or actually worked against improvement trends (for example, significantly fewer patients were sick enough to be in the ICU during their stay in the baseline time period, and the percent of patients with initial BG values ≥ 180 mg/dL at presentation went up across the three time periods). Third, the magnitude of improvement is not feasibly explained by demographic or secular changes.
Our glucometrics include only point-of-care BG values, which have some inherent limitations in accuracy. By excluding glucose values captured in laboratory tests and blood gasses, we miss some glycemic excursions of potential importance. We made this choice because point-of-care BG tests are the most common source of data used to guide care in the hospital setting and to avoid duplicate or "mirror" BG readings. Furthermore, prior studies have established that the addition of laboratory BG readings has minimal impact on hyperglycemia or hypoglycemia rates. [23] Another limitation is that we have not attempted to link the improvements in hypoglycemia and glycemic control to outcomes such as mortality, infection rates, or costs. In the absence of a randomized trial design, controlling for confounders and attributing improvements to glycemic control parameters would be questionable, considering the wide range of ongoing improvement efforts in our medical center in this same time frame.
Conclusion
We used a multidisciplinary approach with multiple mutually reinforcing interventions to cut severe inpatient hypoglycemia by more than half, while simultaneously improving glycemic control. Active DOI:10.4158/EP14367.OR © 2014 AACE.
surveillance (measure-vention) and a hypoglycemia reduction bundle, coupled with ongoing education and robust standardized order sets and documentation were the keys to success.
It is hard to overstate the importance of good glucometric reports to inform the improvement effort, both month to month reports, and real time measurements enabling active surveillance. During the course of this work, we exported our measurement techniques to the SHM website, allowing other sites access to high quality metrics at low or no cost. As described in two of the references [25, 26] , these metrics have also made it possible to compare hospitals to each other, establish benchmarks for performance, and place our performance in perspective. In the last round of published benchmarking [26] , our center placed in the top quartile on both hypoglycemia and glycemic control parameters. This feat was accomplished by only 8 of 76 hospitals, and our center was the only academic center establishing this benchmark. As we prepare to update the extensive SHM glycemic control online resources, we will post examples of how to leverage the EHR to reinforce the insulin management protocols and promote safe use of insulin, along with sharing an array of improvement tools. We believe that well over half of iatrogenic hypoglycemia is preventable. The benchmarking studies reveal extreme variability in glycemic control and hypoglycemia rates, with some sites having hypoglycemia rates 5-6 times our rates. Marked reductions in hypoglycemia are possible if we can disseminate our lessons learned, and the attendant tools, to a broader audience of hospital improvement teams. 
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Failure Mode Hypoglycemia Reduction Bundle Strategies and Solutions
Inappropriate prescribing
• Standardized order sets for subcutaneous insulin, IV insulin, transitions, and monitoring.
• Pre-formatted insulin regimens to match nutritional intake patterns.
• Forcing functions (mandating use of protocol-driven orders)
• Intelligent clinical decision support (CDS) in order sets.
• Elimination of free text insulin orders
• CDS discouraging correction / sliding scale insulin as primary strategy to control hyperglycemia.
• Educational tools for physicians, nursing, pharmacists, and patients.
Glycemic target too low
• CDS to tailor glycemic targets for those at risk of hypoglycemia.
Matching nutritional intake to insulin dosing
• Policies, protocols, and order set CDS for managing unexpected interruption of nutrition.
• Coordination of nutrition delivery, glucose testing, and insulin administration
• Patient and family educational tools.
Failure to
• Hypoglycemia management protocol that features a structured • EHR daily reports of glycemic outliers serve as a stimulus for concurrent intervention, aka measure-vention.
• Glycemic control flow sheets that graphically display glycemic trends and insulin dosing, and pull together other pertinent parameters to assist with management (eg serum creatinine, A1c) assist in measure-vention and also raise awareness of glycemic control issues for the primary inpatient team.
Storing and dispensing
• Insulin concentrations limited to U-100.
• Insulin and syringes are clearly labeled and segregated from other medications.
Administering
• IV bolus and infusion insulin prepared only in pharmacy. Patient Stay averages are day-weighted * p value of < .01; # p value < 0.001, Bonferroni adjusted p value < 0.01
